COVID-19合并心肌梗死患者冠状动脉血栓中中性粒细胞胞外诱捕网的评估
该研究为西班牙单中心连续病例系列,纳入5例COVID-19合并STEMI患者,与50例历史性STEMI患者比较冠状动脉血栓中NETs。COVID-19患者血栓均检出NETs,中位密度61%(95%CI 43%-91%),显著高于历史组的19%(95%CI 13%-22%,P<.001),且血栓由纤维蛋白和多形核细胞组成,无动脉粥样硬化斑块碎片或铁沉积。
要点
- COVID-19合并STEMI患者冠状动脉血栓中NETs密度显著高于非COVID-19的STEMI患者。
- COVID-19患者血栓成分为纤维蛋白和多形核细胞,未见斑块破裂或既往斑块事件证据。
- 靶向血管内NETs可能成为预防重症COVID-19患者冠状动脉血栓的治疗方向。
核心结论
- 在COVID-19合并心肌梗死的小样本病例系列中,NETs似乎在COVID-19相关STEMI的发病机制中起主要作用。
- 研究结果支持靶向血管内NETs可能成为重症COVID-19患者预防冠状动脉血栓的相关治疗目标和可行途径。
研究设计与样本
- 研究为西班牙马德里一家学术三级医院的连续病例系列。
- 纳入2020年3月23日至4月11日期间因STEMI接受直接冠状动脉介入并在导管室使用血栓抽吸装置获取冠状动脉抽吸物的COVID-19患者5例。
- 对照组为2015年7月至2015年12月期间的STEMI患者50例。
- 采用共聚焦显微镜和图像分析检测石蜡包埋冠状动脉血栓中髓过氧化物酶-DNA复合物与瓜氨酸化组蛋白H3的共定位,并进行免疫组化分析。
- 临床和血管造影变量前瞻性收集。
主要发现
- COVID-19组5例患者中4例为男性(80%),平均(SD)年龄62(14)岁;对照组50例中44例为男性(88%),平均(SD)年龄58(12)岁。
- COVID-19组5例患者样本均检出NETs,中位密度为61%(95%CI,43%-91%)。
- 历史STEMI系列50份血栓中34份(68%)检出NETs,中位NET密度为19%(95%CI,13%-22%;P<.001)。
- COVID-19患者所有血栓均由纤维蛋白和多形核细胞组成,均未见动脉粥样硬化斑块碎片或提示既往斑块破裂事件的铁沉积。
临床怎么用
- 对于COVID-19合并STEMI患者,冠状动脉血栓中高密度NETs提示NETs参与血栓形成机制。
- 靶向血管内NETs可能作为重症COVID-19患者预防冠状动脉血栓的潜在治疗目标。
局限性
- 研究为小样本病例系列,COVID-19组仅5例患者。
- 对照组为历史性系列,非同期对照。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Severe coronavirus disease 2019 (COVID-19) is characterized by the intense formation of neutrophil extracellular traps (NETs), leading to the occlusion of microvessels, as shown in pulmonary samples. The occurrence of ST-elevated myocardial infarction (STEMI) is a serious cardiac manifestation of COVID-19; the intrinsic mechanism of coronary thrombosis appears to still be unknown. OBJECTIVE: To determine the role of NETs in coronary thrombosis in patients with COVID-19. DESIGN, SETTING, AND PARTICIPANTS: This was a consecutive series of patients with COVID-19 at an academic tertiary hospital in Madrid, Spain, who underwent primary coronary interventions for STEMI in which coronary aspirates were obtained in the catheterization laboratory using a thrombus aspiration device. Patients with COVID-19 who experienced a STEMI between March 23 and April 11, 2020, from whom coronary thrombus samples were aspirated during primary coronary intervention, were included in the analysis. These patients were compared with a series conducted from July 2015 to December 2015 of patients with STEMI. MAIN OUTCOMES AND MEASURES: The presence and quantity of NETs in coronary aspirates from patients with STEMI and COVID-19. The method for the analysis of NETs in paraffin-embedded coronary thrombi was based on the use of confocal microscopy technology and image analysis for the colocalization of myeloperoxidase-DNA complexes and citrullinated histone H3. Immunohistochemical analysis of thrombi was also performed. Clinical and angiographic variables were prospectively collected. RESULTS: Five patients with COVID-19 were included (4 men [80%]; mean [SD] age, 62 [14] years); the comparison group included 50 patients (44 males [88%]; mean [SD] age, 58 [12] years). NETs were detected in the samples of all 5 patients with COVID-19, and the median density of NETs was 61% (95% CI, 43%-91%). In the historical series of patients with STEMI, NETs were found in 34 of 50 thrombi (68%), and the median NET density was 19% (95% CI, 13%-22%; P < .001). All thrombi from patients with COVID-19 were composed of fibrin and polymorphonuclear cells. None of them showed fragments of atherosclerotic plaque or iron deposits indicative of previous episodes of plaque rupture. CONCLUSIONS AND RELEVANCE: In this small case series of patients with COVID-19 and myocardial infarction, NETs seem to play a major role in the pathogenesis of STEMI in COVID-19 disease. Our findings support the idea that targeting intravascular NETs might be a relevant goal of treatment and a feasible way to prevent coronary thrombosis in patients with severe COVID-19 disease.
引用
- Blasco A, Coronado MJ, Hernández-Terciado F, et al. Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients With COVID-19 and Myocardial Infarction. JAMA Cardiol. 2021. PMID: 33372956. doi:10.1001/jamacardio.2020.7308
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。